Wearable vibration device added to physiotherapy for arm weakness after stroke
Tests a wearable vibration device alongside physiotherapy in people with arm weakness after stroke.
Plain-language title generated from the registry record
Registry title: Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients
Key facts
- Where
- Faisalābad, PakistanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 60 years old?
Source: NCT07641790, who can take part
Where in Pakistan
- The University of FaisalabadFaisalābad, PakistanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Faisalabad
- Trial code
- NCT07641790
- Record updated
- 11 June 2026
- Original description
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.Read full original descriptionShow less
Effects of Wearable Vibratory Devices for Upper Limb Function Among Subacute Hemiplegic Patients: A Randomized Controlled Trial
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Inclusion: Unilateral hemiplegia secondary to stroke; Age between 30 and 60 years; Subacute stage (3 to 6 months post-stroke); Fugl-Meyer Assessment (FMA) score between 20 and 50; Able to follow simple verbal commands.
Exclusion: Previous peripheral nerve injury or surgery affecting the upper limb; Co-existing neurological conditions (e.g., Parkinson's, MS, Dementia); Unstable cardiovascular conditions; Fixed contractures or bony fractures in the affected limb; Complete sensory loss of the upper limb.